$543.29
arrow_drop_up1.22%Intuitive Surgical Inc (ISRG) demonstrates strong financial health through key fundamental indicators. The company's price-to-earnings (P/E) ratio of 80.21 suggests that investors are willing to pay a premium for the stock based on its earnings performance. Additionally, the return on equity (ROE) of 14.83% indicates that the company efficiently utilizes shareholder's funds to generate profits. With a debt-to-equity ratio of 0.01, ISRG maintains a low level of debt compared to its equity, reflecting a conservative approach to financial leverage. Furthermore, the high gross margin of 66.39% and net margin of 25.24% showcase the company's ability to generate profits from its core operations effectively. Moreover, Intuitive Surgical Inc's strong revenue growth of 14.49% highlights the company's ability to increase its top line consistently. The impressive earnings growth year-over-year of 35.18% indicates a robust profitability trend and a promising outlook for future earnings. The company's solid current ratio of 4.76 and quick ratio of 4.02 demonstrate strong liquidity positions, ensuring the ability to meet short-term financial obligations. Additionally, the company's free cash flow margin of 10.52% reflects the efficiency of the company in generating cash flow from its operations. Overall, ISRG's fundamental analysis showcases a financially stable and lucrative investment opportunity for potential investors.
Intuitive Surgical, Inc. has been recognized as a top healthcare stock, and a beaten-down growth stock with potential value to add for long-term investors. The company has outperformed its competitors despite losses on the day, indicating a strong performance in a competitive market. The company has received attention from Zacks.com users, suggesting a strong investor interest. Intuitive Surgical, Inc. has been listed as a multibagger stock in the making, with a high potential for growth.
The company's stock has underperformed compared to competitors, indicating potential weakness in the market. The stock has seen a decrease in value, indicating potential investor disinterest. The company's cash ratio is low, which could indicate financial instability.
Intuitive Surgical Inc (ISRG) has a neutral technical rating, with indicators such as ATR, RSI, MACD, ADX, and ROC signaling a hold position in the market. The stock's price closed at $401.78, registering a price change of $3.88 or 0.98%. The technical analysis also highlights that there were 1 buy indicator, 4 hold indicators, and 3 sell indicators in the past month, suggesting a mixed sentiment among investors. Furthermore, the stock's trailing PE ratio is 79.42 and it has a beta of 1.36, indicating moderate volatility compared to the market. Additionally, the company's stock sector is Healthcare, which has seen a significant change of 28.75% in the past year. The sector quality score is rated at 89, indicating strong fundamentals and growth potential within the industry. ISRG has a cumulative multiple of 4.5 and a market cap of $141.49B, reflecting its position as a major player in the healthcare sector. The technical analysis also points out that the stock has 352.33M shares outstanding and has undergone a 3:1 stock split in the past, which could have implications on its price movement and liquidity in the market.
Based on the data provided, Intuitive Surgical Inc (ISRG) appears to be a strong investment opportunity in the healthcare sector. With a high market score of 78 and a strong industry quality score of 100, the company has shown consistent growth and stability. Its innovative products and services in the field of robotic-assisted surgery have positioned it as a market leader, reflected in its impressive revenue growth of 14.49% and net income of $1.82 billion. Additionally, the company's strong financial position, with assets totaling $15.44 billion and a debt-to-equity ratio of just 0.01, indicates solid management and strategic planning. In conclusion, Intuitive Surgical Inc presents a compelling investment opportunity for those looking to capitalize on the healthcare industry's growth potential. With a diversified product portfolio, strong financial performance, and positive analyst recommendations, the company is well-positioned for future success. While there are risks associated with any investment, the overall outlook for ISRG appears positive, and investors may consider adding this stock to their portfolio for long-term growth and value appreciation.